- $963.97m
- $804.67m
- $251.70m
- 91
- 32
- 56
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 213 | 226 | 250 | 280 | 252 |
Cost of Revenue | |||||
Gross Profit | 164 | 175 | 197 | 224 | 204 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 230 | 208 | 217 | 227 | 213 |
Operating Profit | -17.1 | 17.7 | 33.4 | 53.1 | 38.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -16.4 | 19.1 | 31.6 | 52.7 | 43.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.8 | 17.8 | 94.9 | 46.9 | 40 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -17.8 | 17.8 | 94.9 | 46.9 | 40 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.8 | 17.8 | 94.9 | 46.9 | 40 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.213 | 0.223 | 1.19 | 0.603 | 0.529 |
Dividends per Share |